Mounjaro injection technique and missed doses: what's accurate?

What did @farmacia_dott_masi actually say?

Honestly, not much that we can evaluate. The transcript provided for this video is effectively incoherent, a string of generic English phrases that bear no relationship to the Italian-language caption, which promises viewers a guide on correct Mounjaro injection technique, injection sites, and missed-dose instructions. What the caption claims and what the transcript contains are two completely different things.

The caption reads: "Come usare Mounjaro. Iniezione corretta, dove farla e cosa fare se salti una dose" — in plain English, how to use Mounjaro, the correct injection, where to do it, and what to do if you miss a dose. That is a specific, clinically relevant set of claims. The transcript, by contrast, includes lines like "the company is a Each and every time you have to go" and "subscribe to our channel." There is no usable quote to evaluate.

We are fact-checking the caption's stated claims alongside what a video with this title would typically assert, because that is the content 313,800 viewers were served.

Does the science back up standard Mounjaro injection guidance?

Yes, for the most part. The core injection advice for tirzepatide (Mounjaro's active ingredient) is well-established and consistent across the prescribing information and clinical literature. The science here is not contested.

Tirzepatide is a once-weekly subcutaneous injection. The approved injection sites are the abdomen, thigh, or upper arm, and users should rotate sites within those areas to reduce lipohypertrophy, a known complication of repeated injections at the same spot. Hirsch et al. (2014, Diabetes Care) documented that lipohypertrophy from poor rotation leads to erratic drug absorption and unpredictable glycemic outcomes. That finding applies directly to GLP-1 and dual GIP/GLP-1 agonists like tirzepatide.

On missed doses: the Mounjaro prescribing information states that if a dose is missed and the next scheduled dose is more than four days away, the missed dose can be administered. If fewer than four days remain, skip the missed dose. This is not a trivial distinction. Doubling up on a tirzepatide dose increases the risk of nausea, vomiting, and gastrointestinal distress significantly, based on adverse event data from the SURMOUNT trials (Jastreboff et al., 2022, New England Journal of Medicine).

What did they get wrong, or right?

We cannot definitively score the creator's specific statements because the transcript is unusable. What we can say is this: a registered pharmacist posting under a verified pharmacy account in Italy is operating under EU pharmaceutical regulations, which do require dispensing professionals to provide accurate medication guidance. The caption's framework, injection site, technique, missed dose, is the right framework to teach.

If the video does cover injection sites correctly and includes the four-day missed-dose window accurately, that is responsible content. Many injection tutorial videos get the missed-dose rule wrong, defaulting to a vague "take it as soon as you remember" instruction that does not apply to long-acting weekly injectables the same way it applies to daily oral medications.

One flag worth noting: the video has no visible reference to whether it was produced under the supervision of a prescriber or is intended to replace one-on-one pharmacist counseling. Injection technique guidance is appropriate from a pharmacist. Dosing decisions are not.

What should you actually know?

If you are using Mounjaro, these are the points that actually matter, drawn from the prescribing information and clinical trial data, not social media.

• Inject subcutaneously into the abdomen, thigh, or upper arm. Never inject into muscle or a vein.
• Rotate your injection site every week. Using the same spot repeatedly causes tissue changes that affect how the drug is absorbed.
• The missed-dose rule is specific: four days is the cutoff. Do not take a double dose. The SURMOUNT-1 trial data shows dose-dependent gastrointestinal side effects, and doubling up is not safe or effective.
• Store Mounjaro pens in the refrigerator. They can be kept at room temperature, below 30 degrees Celsius, for up to 21 days.
• Tirzepatide is not the same as semaglutide. They work on overlapping but distinct receptor pathways, and compounded versions of either drug are not equivalent to the branded product in terms of verified dosing, sterility, or stability.

A pharmacist tutorial is a useful supplement to formal prescriber counseling. It is not a replacement for it. If you have questions about your specific dose, your injection schedule, or side effects you are experiencing, that conversation belongs with the clinician who prescribed the medication.